We are live on ! Find out more
PASG icon

Passage Bio
PASG

35 hedge funds and large institutions have $13.8M invested in Passage Bio in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

17% more funds holding

Funds holding: 30 → 35 (+5)

5.87% more ownership

Funds ownership: 49.62% → 55.49% (+5.9%)

26% less capital invested

Capital invested by funds: $18.6M → $13.8M (-$4.78M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
6
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
Ikarian Capital
Texas
+$705K
2
YCM
Yiheng Capital Management
California
+$536K
3
UBS Group
UBS Group
Switzerland
+$270K
4
Renaissance Technologies
Renaissance Technologies
New York
+$254K
5
VA
Verdad Advisers
Massachusetts
+$229K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$208K
2
Northern Trust
Northern Trust
Illinois
-$168K
3
QC
Quadrature Capital
United Kingdom
-$148K
4
Squarepoint
Squarepoint
New York
-$127K
5
NCNMGF
Nano-Cap New Millennium Growth Fund
New York
-$118K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
1
Lynx1 Capital Management
Puerto Rico
$4.9M – – –
VPC
2
Vestal Point Capital
New York
$2.39M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$1.05M +$254K +24,523 +22%
EP
4
Eversept Partners
New York
$1.03M +$55.4K +5,351 +4%
VCM
5
Vanguard Capital Management
Pennsylvania
$895K +$1.18M +113,964 New
YCM
6
Yiheng Capital Management
California
$676K +$536K +51,796 +151%
IC
7
Ikarian Capital
Texas
$535K +$705K +68,124 New
EAM
8
Erste Asset Management
Austria
$527K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$325K +$103K +9,983 +32%
BlackRock
10
BlackRock
New York
$224K -$3.19K -308 -1%
UBS Group
11
UBS Group
Switzerland
$216K +$270K +26,059 +1,807%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$189K – – –
VA
13
Verdad Advisers
Massachusetts
$174K +$229K +22,128 New
DP
14
Diadema Partners
New Jersey
$153K +$202K +19,530 New
BFM
15
Boothbay Fund Management
New York
$148K +$195K +18,871 New
VFT
16
Vanguard Fiduciary Trust
Pennsylvania
$134K +$176K +17,049 New
XT
17
XTX Topco
Cayman Islands
$99.1K +$131K +12,627 New
FT
18
Fiduciary Trust
Massachusetts
$84.4K – – –
PAP
19
Persistent Asset Partners
Hong Kong
$38.9K +$51.3K +4,955 New
Morgan Stanley
20
Morgan Stanley
New York
$20.8K -$16.8K -1,625 -38%
Rockefeller Capital Management
21
Rockefeller Capital Management
New York
$6.28K +$3.1K +300 +60%
VGA
22
Vanguard Global Advisers
Pennsylvania
$5.01K +$6.6K +638 New
TRCT
23
Tower Research Capital (TRC)
New York
$3.94K +$5.2K +502 New
Barclays
24
Barclays
United Kingdom
$1.66K – – –
SS
25
SBI Securities
Japan
$973 -$186 -18 -13%
1
2

PASG Hedge Fund Activity: Q1 2026 in Review

35 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q1 2026, worth a combined $13.8M — down 26% from $18.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new PASG positions and 6 closed out — a net gain of 6 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $705K. The largest seller was Citadel Advisors, exiting entirely with an estimated $208K sold.

  • 35 institutional investors held Passage Bio (PASG) as of Q1 2026, up from 30 in Q4 2025.
  • Funds reported $13.8M of Passage Bio stock for Q1 2026, down 26% quarter-over-quarter.
  • 12 funds opened new Passage Bio positions in Q1 2026 and 6 closed out, a net change of +6 holders.
  • The largest Passage Bio buyer in Q1 2026 was Ikarian Capital, an estimated $705K added.
  • The largest Passage Bio seller in Q1 2026 was Citadel Advisors, an estimated $208K sold.

Based on aggregated 13F filings for Q1 2026.